1. Home
  2. Detail

@gayerfinalboss:

ScArlet queen
ScArlet queen
Open In TikTok:
Region: CA
Sunday 21 June 2026 22:04:50 GMT
240
11
0
0

Music

Download

No Watermark .mp4 (1.6MB) No Watermark(HD) .mp4 (1.6MB) Watermark .mp4 (4.84MB) Music .mp3

Comments

There are no more comments for this video.
To see more videos from user @gayerfinalboss, please go to the Tikwm homepage.

Other Videos

Jatuh cinta lagi dengan mantan pacarku #pinedrama #id #pinedramaid #dramapendek
Jatuh cinta lagi dengan mantan pacarku #pinedrama #id #pinedramaid #dramapendek
صوت بَاسم… #viral#fyp#اللهم_صل_على_محمد_وآل_محمد#تصويري#foryou
صوت بَاسم… #viral#fyp#اللهم_صل_على_محمد_وآل_محمد#تصويري#foryou
Best place on earth 🌎 #characters #persona #realdiamondjackson
Best place on earth 🌎 #characters #persona #realdiamondjackson
Healthcare stocks that’s 50% undervalued Revenue: $1.4B+ (2025E) — up 55% YoY EBITDA: $200M+ (2025E) — up 170% YoY Net Income Q3: $41M — up 900% YoY Gross Margin: 45.5% EBITDA Margin: 16.4% — up 990 bps YoY Clinics: 252 across Canada — largest network in the country Patient Visits: 4.3M in 2025 — up 37% YoY Providers: 3,100+ — up 27% YoY Market Cap: ~$1.0B SOTP Value: ~$2.0B+ Discount: ~50% Analyst Target: $7.50 (high $9.00) Stock Price: ~$4.00 WELLSTAR (majority-owned SaaS subsidiary) Revenue: $74M+ (2025E) — growing 67% YoY Organic Growth: 26% ARR: $80M exit target Gross Margin: 80%+ EBITDA Margin: 30-35% Recurring Revenue: 90% Private Valuation: $535M (Dec 2025) 40% of all Canadian doctors use a WELLSTAR product IPO: Targeting TSX 2026​​​​​​​​​​​​​​​​ #well #stocks #investing
Healthcare stocks that’s 50% undervalued Revenue: $1.4B+ (2025E) — up 55% YoY EBITDA: $200M+ (2025E) — up 170% YoY Net Income Q3: $41M — up 900% YoY Gross Margin: 45.5% EBITDA Margin: 16.4% — up 990 bps YoY Clinics: 252 across Canada — largest network in the country Patient Visits: 4.3M in 2025 — up 37% YoY Providers: 3,100+ — up 27% YoY Market Cap: ~$1.0B SOTP Value: ~$2.0B+ Discount: ~50% Analyst Target: $7.50 (high $9.00) Stock Price: ~$4.00 WELLSTAR (majority-owned SaaS subsidiary) Revenue: $74M+ (2025E) — growing 67% YoY Organic Growth: 26% ARR: $80M exit target Gross Margin: 80%+ EBITDA Margin: 30-35% Recurring Revenue: 90% Private Valuation: $535M (Dec 2025) 40% of all Canadian doctors use a WELLSTAR product IPO: Targeting TSX 2026​​​​​​​​​​​​​​​​ #well #stocks #investing


ổng thà chịu nắng chứ khong để bạn gái chịu nóng 🥰. Tinh tế vãiii #xuhuongtiktok #tinhte #xuhuonggggg #fyp
ổng thà chịu nắng chứ khong để bạn gái chịu nóng 🥰. Tinh tế vãiii #xuhuongtiktok #tinhte #xuhuonggggg #fyp

About

Legal